Evidence map›Paper›PMID 39340110›Full record

ArticleVaccines2024

Changes in Attitudes towards Influenza and Pneumococcal Vaccination during the Subsiding COVID-19 Pandemic-Results of a Longitudinal Survey Study among Risk Groups in Germany between 2021 and 2023.

Sebastian Born, Daniel Schwarzkopf, Norman Rose, Mathias W Pletz, Konrad Reinhart, Carolin Fleischmann-Struzek

Abstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sebastian BornInstitute of Infectious Diseases and Infection Control, Jena University Hospital, 07743 Jena, Germany.ORCID 0000-0001-5803-7963
Daniel SchwarzkopfDepartment of Anesthesiology and Intensive Care Medicine, Jena University Hospital, 07743 Jena, Germany.ORCID 0000-0002-1568-8202
Norman RoseInstitute of Infectious Diseases and Infection Control, Jena University Hospital, 07743 Jena, Germany.
Mathias W PletzInstitute of Infectious Diseases and Infection Control, Jena University Hospital, 07743 Jena, Germany.ORCID 0000-0001-8157-2753
Konrad ReinhartDepartment of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Carolin Fleischmann-StruzekInstitute of Infectious Diseases and Infection Control, Jena University Hospital, 07743 Jena, Germany.

Funding

German Innovations Fund of the Federal Joint Committee 01VSF19020
6 · The paper itself

Abstract

backgroundIn many countries, an increase in influenza and pneumococcal vaccination rates was observed during the COVID-19 pandemic. We examined how attitude, risk perception and knowledge towards influenza and pneumococcal vaccines of at-risk patients developed when the COVID-19 pandemic subsided and if COVID-19 vaccination attitude (VA) was still associated with the attitudes towards the two other vaccines.

methodsWe used longitudinal data from two surveys conducted in Germany in 2021 and 2023 among persons with chronic diseases. We assessed VA, risk perception, vaccination knowledge and further psychological determinants of vaccine acceptance. Structural equation modelling using full information maximum likelihood was used to estimate multivariate regressions with planned missing data.

resultsAmong 543 respondents, the influenza and pneumococcal vaccination rates remained relatively stable between 2021 and 2023. VA also remained unchanged at a moderately positive level, while COVID-19 VA decreased. A constantly positive association between COVID-19 VA and influenza as well as pneumococcal VA was found, independent from a general VA. The perceived danger of influenza increased between 2021 and 2023 and was among the strongest predictors of influenza VA.

conclusionsAlso at the subsiding pandemic, COVID-19 VA was constantly associated with the influenza and pneumococcal VA. It seems sensible to take these aspects into account when designing future vaccination campaigns for at-risk patients.

trial registrationDRKS00024561. Registered 9 March 2021.

Indexed as

COVID-19influenzapneumococcalrisk perceptionvaccination attitude

Identifiers

PMID39340110
PMCPMC11435497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.